CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.44 ($110,075)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.45 ($56,363)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.44 ($109,575)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.44 ($111,163)
- NT 10-K Other NT 10-K
- 4 Open-market buy 10% owner bought 125,000 shares at $0.45 ($55,738)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.45 ($112,538)
- 4 Open-market buy 10% owner bought 250,000 shares at $0.46 ($114,725)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.46 ($57,563)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.46 ($114,875)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.46 ($113,963)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.49 ($61,350)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.49 ($61,225)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.47 ($117,125)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.48 ($60,400)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.53 ($133,413)
- 4 Open-market buy 10% owner bought 250,000 shares at an average $0.52 ($129,338)
- 4 Open-market buy 10% owner bought 125,000 shares at $0.49 ($60,963)
Page 19 of 38 · 760 filings